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1. Introduction
The most significant prognostic factors in breast cancer are the tumoral diameter, tumor
grading  and  the  status  of  the  axillary  lymph  nodes.  The  presence  of  nodal  metastases
decreases 5-year  survival  by approximately 40% compared to node-negative patients,  in
reference [1]. Lymph node status is of particular value in choosing further therapy. Lymph
node metastatic  disease  is  an indication for  skipping sentinel  node biopsy (SLNB)  (and
proceeding  to  complete  axillary  dissection)  and/or  for  adjuvant  systemic  chemotherapy,
which may be of benefit if administered as preoperative treatment.
2. The anatomy of the axillary lymph node
The anatomy of the axillary lymph node includes the cortex and the medulla. The high-
frecquency  probes  allow  the  differentiation  of  the  central  echogenic  hilum  and  the
peripheral  hypoechoic  cortex.  The  cortex,  which  includes  the  marginal  sinus  and  the
lymphoid follicles is hypoechoic and thin, and has a fusiform shape with smooth edge. The
hilum is the hyperechoic, its echogenity being attributable to multiple reflective interfaces
of blood vessels, fat, and the central sinus, in reference [2,3].
Carcinoma from the breast enters the lymph node via the afferent lymphatics, penetrates the
capsule, and enters the subcapsular sinus, in reference [4]. Metastatic cells firstly stop in the
periphery (cortex) of the nodes, causing cortical enlargement. Then generalized cortical
enlargement and destruction of the nodal architecture occurs, with compression and, eventu‐
ally, loss of the hilum, in reference [2].
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3. Assessment of axillary lymph nodes status
Grossly involvement of axillary lymph nodes can be detected by clinical examination,
ultrasound or axilla MRI. However, introduction of screening mammography led to earlier
diagnosis of breast cancer, in which axillary involvement is frequently absent. The challenge
of imaging technique is to differentiate the normal lymph nodes from the nodes with minimal
metastatic disease, which do not change the size and shape of the lymph node, in patients with
small primary breast tumors.
The “golden standard” for axillary lymph node status is pathological examination of lymph
nodes. There are three possibilities to obtain information regarding the axillary lymph nodes
status: complete axillary lymph node dissection, biopsy of the sentinel lymph node (SLN) and
pretreatment imaging of the axillary lymph nodes, associated or not with fine-needle aspira‐
tion cytology or core biopsy of the suspicious nodes.
Complete lymph node dissection represents the classic approach that allows pathological
examination of all the lymph nodes in the axilla. However, complete axillary lymph node
dissection is accompanied by complications like seroma formation, numbness, limitation of
shoulder movement, and lymphedema, in reference [5].
SLN biopsy (SLNB) represents the biopsy of that lymph node, which first collects the lymph
from the breast. It is a surgical procedure, requiring preoperative administration of a dye and/
or radionuclide tracer.
Pretreatment imaging of the axillary lymph nodes must closely match the pathological findings
in order to have any value for clinical decision making. Many studies suggest that patients
with axillary involvement may benefit from preoperative systemic treatment. Imaging
techniques for axilla include ultrasound, MRI enhanced or nonenhanced, FDG-PET scan,
99mTc-sestamibi scintigraphy.
4. Ultrasound evaluation of axilla
The most available imaging technique for axilla is ultrasound. Ultrasound has two roles in
visualizing the axilla: a) to characterize the abnormal lymph nodes, either identified by US or
by clinical examination or other imaging technique and b) to help axillar SLN identification.
In both circumstances, ultrasound helps the biopsy of the nodes.
Afferent lymphatic channels enter a node through the periphery of the cortex, so the malignant
cells travelling the lymphatic vessel will first stop in the cortical region of the lymph node.
Most of the US signs of lymph nodes metastasis will refer to the abnormalities of the cortex.
Subtle abnormalities of the cortex can indicate early metastatic involvement.
For the assessment of a lymph node by US, quantitative or qualitative methods have been used.
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4.1. The qualitative features of a metastatic lymph node on US
The qualitative features of a metastatic lymph node on US include shape (round morphology),
asymmetric cortical thickening (Figure 1), loss of central hilum, loss or compression of the
hyperechoic medullary region (Figure 2), relationship with neighbouring lymph nodes, left-
to-right asimetry and increased peripheral blood flow. Even more, lymph nodes can exhibit
ultrasound malignancy signs characteristic to the primary breast tumor, such as angular
margins, „taller than wide” (Figure 3) or they appears intensely vascularisated on Doppler
ultrasound. Reactive changes associated with inflamation produce an increase of blood flux
in the preexisting blood vessels, but do not generate new vessel formation or vessels that can
penetrate the capsule. Metastatic disease stimulates new vessels formation, so Doppler
examination can reveal an intense Doppler signal inside the lymph node or blood vessel
penetrating the capsule.
The qualitative features of a metastatic lymph node on US include shape (round 
morphology), asymmetric cortical thickening (Figure 1), loss of central hilum, loss or 
compression of the hyperechoic medullary region (Figure 2), relationship with neighbouring 
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lymph node or blood vessel penetrating the capsule. 
 
 
 
Figure 1. Left: Metastatic lymph node, with a round shape. Invasive ductal carcinoma 
(primary tumor of 1.8 cm, three SLNs identified, all of them metastatic, and complete 
axillary dissection). Right: asymmetrical cortical thickening in a metastatic axillary lymph 
node (with normal the cortex-hilum area ratio).  
 
 
 
Figure 2. Metastatic lymph node. Left: loss of the hyperechoic medullary region. Right: on 
power Doppler examination, this node is displaying both central and peripheral blood flow. 
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Figure 2. Metasta ic lymph node. Left: loss of the hyperechoic medullary reg on. Right: on power Doppler exami a‐
tion, this node is displaying both central and peripheral blood flow.
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Figura 3. Left, metastatic lymphadenopathy, exhibiting „taller than wide” property and 
angular margins. Pathology showed capsular efraction. Right, gigantic metastatic 
lymphadenopathy with increased vascularisation and intact capsule. 
 
 
4.2 The quantitative indicators of a metastatic lymph node on US 
 
The quantitative indicators of a metastatic lymph node on US include the size (Figure 4, 
left), maximum thickness of the cortex, in reference [6] (Figure 4, right; Figure 5), the cortex-
hilum (CH) area ratio, in reference [7] (Figure 5), the longitudinal-transverse (LT) axis ratio, 
in reference [7], the number of peripheral blood vessels. 
Lymph nodes can be enlarged, either by metastatic disease or reactive changes, including fat 
degeneration. Reactive changes in lymph nodes increase all dimensions, keeping the 
eliptical shape and a normal cortical/medullar index. Metastatic disease will increase the 
lymph node small diameter, will replace the medullar hyperechogenic region with 
hypoechogenic tumoral tissue, so the maximum thickness of the cortex and cortex-hilum 
area ratio will increase, eventually completely destroying the hilum (absent hilum). 
A small study of the author, in reference [8], evaluating 21 consecutive breast cancer 
patients, in which SLNB was performed, suggest that ultrasound size > 1 cm of lymph 
nodes correlates with invasion of SLN (Figure 4, left). 
 
 
Figure 3. Left, m tastatic lymphadenopat y, exhibiting „tall r than wide” property nd angular margins. Pathology
showed capsular efraction. Right, gigantic metastatic lymphadenopathy with increased vascularisation and intact cap‐
sule.
4.2. The quantitative indicators of a metastatic lymph node on US
The quantitative indicators of a metastatic lymph node on US include the size (Figure 4, left),
maximum thickness of the cortex, in reference [6] (Figur  4, right; Fig re 5), the cortex-hilum
(CH) area ratio, in reference [7] (Figure 5), the longitudinal-transverse (LT) axis ratio, in
reference [7], the number of peripheral blood vessels.
Ly ph nodes can be enlarged, either by etastatic disease or reactive changes, including fat
ti . Reactive changes in lymph nodes increase all dimensions, keeping the eliptical
shape nd  normal cortical/medullar ind x. Metastatic dis ase will increase the lymph nod
small diameter, wil  repl ce the medullar hyp rechogenic region with hypo chogenic tumoral
tissue, s  the maximum thickness of the cortex and cortex-hilum area ratio will increase,
eventually completely destroying the hilum (absent hilum).
A small study of t e author, in reference [8], evaluating 21 consec tive br ast cancer patients,
in whi h SLNB was performed, suggest that ultrasound size > 1 cm of lymph nodes correlates
with invasion of SLN (Figure 4, left).
Cortical region evaluation is more important in lymph nodes assessment than size. The
absolute cortical thickness is predictive for axillary metastatic disease (Figure 4, right), a
cortical thickness more than 2.5 mm being associated in 70 percent of cases with lymph node
metastasis (Cho N et al, 2009, in reference [6]).
Song SE et al, in reference [7], evaluated the diagnostic performance for their own positive
criteria for lymph node metastasis, such as CH area ratio >2 (Figure 5), LT axis ratio <2 or
peripheral type of vascularisation on power Doppler imaging. They found that the sensitivity
of the CH area ratio was superior to that of the LT axis ratio (94.1% vs. 82.3%, p=0.031) and to
that of the peripheral blood flow pattern (94.1% vs. 29.4%, p=0.009) (Figure 6). For specificity,
all three parameters had the same high values (89.1-95.6%; NS).
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Figure 4. Left: metastatic lymph node, showing increased size (longest dimension of 2,29 
cm), in a case of advanced invasive ductal carcinoma. Core biopsy of this node showed 
invasive duct carcinoma. Right: maximum thickness of the cortex of 4 mm in a metastatic 
lymph node (invasive ductal carcinoma). 
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Figure 5. Above: reactive lymphadenopathy in patient with postpartum mastitis. There is 
moderate and simetrical increase of cortical thickness, but normal cortical/medullar index. 
Below: metastatic axillary lymph node with cortical/medullar index of 1.82 and an absolute 
increase of cortical thickness > 2.5 mm. 
 
Song SE et al, in reference [7], evaluated the diagnostic performance for their own positive 
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sensitivity of the CH area ratio was superior to that of the LT axis ratio (94.1% vs. 82.3%, p= 
0.031) and to that of the peripheral blood flow pattern (94.1% vs. 29.4%, p=0.009) (Figure 6). 
For specificity, all three parameters had the same high values (89.1-95.6%; NS). 
 
Figure 5. Above: reactive lymphadenop thy in patient wit  postpartum mastitis. There is moderate and simetrical in‐
crease of cortical thickness, but normal cortical/medullar index. Below: metastatic axillary lymph node with cortical/
medullar index of 1.82 and an absolute increase of cortical thickness > 2.5 mm.
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Figure 6. Metastatic axillary lymph node with LT axis ratio of 1.50; blood flow was absent on power Doppler.
4.3. Sonoelastography
Sonoelastography can be added to axillary lymph nodes ultrasound evaluation for further
increase the precision of identification of metastatic lymph nodes. At present, there are not
many studies trying to establish the place of sonoelastography in evaluation of axillary lymph
nodes status. Choi (2011, 64 patients, in reference [9]), Taylor (2011, 50 patients, in reference
[10]), Wojcinski (2012, 180 patients, in reference [11]) found that sonoelastography is capable
of detecting elasticity differences between the cortex and medulla, and between metastatic and
healthy LNs.
Wojcinski et al (2012) found that the highest sensibility (73.3%) is obtained when cortex >3mm
in B-mode OR blue cortex in the elastogram, while, when these two features are found together
(cortex >3mm in B-mode AND blue cortex in the elastogram (Figure 7)), the highest specificity
is obtained (99.3%).
4.4. The role of ultrasound in sentinel lymph node identification and biopsy
Ultrasound has a role in sentinel lymph node identification. With introduction of indocyanine
green for sentinel lymph node biopsy (SLNB), Tagaya et al (2010) were able to visualize the
fluorescence of lymphatic vessels on the skin. The authors performed firstly intraoperative
ultrasonography to identify a SLN as the first lymph node recognized during ultrasonography
scanning from the edge of the breast gland in the direction of the axilla and they marked its
position on the axillary skin. After indocyanine green dye injection, lymphatic ducts were
visualized towards the axilla and the fluorescence stream disappeared aproximatively 1 cm
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before the line marked on the skin for ultrasound SLN location. In this study, the sites of skin
incision for SLNB were also identical with the LN that had been demonstrated by ultrasonog‐
raphy in all patients.
Ultrasound signs of SLN involvement could be very subtle, with only a minimal focal cortical
thickness increase.
By recognizing the first lymph node during scanning towards axilla (Figure 8), ultrasound
may help SLN identification and decrease the operation time, an important fact because as the
identification time increase, more SLNs are found.
However, in case of axillary metastases, identification of SLN may be impaired (Esen G, Gurses
B, 2005, in [12]).
4.5. The role of ultrasound in imagistic staging of breast cancer
Ultrasound could have a role in imagistic staging of breast cancer. Knowledge of axillary
lymph node involvement before surgery may allow for individualization of multimodal
treatment. This may include preoperative chemotherapy, intraoperative breast radiotherapy
or plastic surgery for immediate reconstruction.
The future protocols of breast cancer treatment will probably include ultrasound as a step in
preoperative sentinel node mapping. Ultrasound may reveal abnormalities of axillary lymph
nodes and guide biopsy of these nodes.
Figure 7. Wojcinski et al, 2012, in reference [11]. Open Access. Example for B-mode ultrasound and elastogram of a
metastatic LN. In B-mode ultrasound, the cortex of the LN is slightly enlarged (maximum ~3.5mm). The predominant
color of the medulla is turquoise (to green) and the cortex is mainly blue. Meeting both criteria of cortex >3mm in B-
mode AND blue cortex in the elastogram, this case would be a true-positive.
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Patients with either normal or abnormal ultrasound exams, but negative cytology, underwent
sentinel node mapping. Patients with abnormal ultrasound and positive cytology proceeded
to complete axillary dissection, in reference [13].
There are studies trying to assess the tumoral burden in patient with positive nodes. The study
of Moore A et al, in [13], indicates that abnormalities limited to the lymph node cortex (Figure
9) were indicative of N1 disease.
Ultrasound features of axilla, suggesting metastasis in lymph nodes, combined with results of
cytology or biopsy, could modify the surgical approach to the axilla, eliminating the need for
sentinel node mapping in a significant proportion of patients, in reference [13].
Loss or compression of the hyperechoic medullary region, absence of fatty hilum, abnormal
lymph node shape and increased peripheral blood flow are predictive of N2–3 disease, in
reference [13] (Figure 10).
 
 
 
Figure 8. Above: preoperative assessment of axilla in a breast cancer patient with 
preoperative chemotherapy. The first lymph node during scanning towards axilla: sentinel 
lymph node with normal size (longest dimension 5.9 mm) and shape, but with smal focal 
cortical thickness. Below: intraoperative identification of SLN. After complete axillary 
dissection, the sentinel lymph and all the other nodes were negative. 
 
By recognizing the first lymph node during scanning towards axilla (Figure 8), ultrasound 
may help SLN identification and decrease the operation time, an important fact because as 
the identification time increase, more SLNs are found.  
However, in case of axillary metastases, identification of SLN may be impaired (Esen G, 
Gurses B, 2005, in [12]).  
 
4.5 The role of ultrasound in imagistic staging of breast cancer 
 
Ultrasound could have a role in imagistic staging of breast cancer. Knowledge of axillary 
lymph node involvement before surgery may allow for individualization of multimodal 
treatment. This may include preoperative chemotherapy, intraoperative breast radiothe apy 
or plastic surgery for immedi te reconstruction. 
Figure 8. Above: preoperative assessmen  of axilla in a breast cancer p tie t with preoperative chemotherapy. The first
lymph node during scanning towards axilla: sentinel lymph node with normal size (longest dimension 5.9 mm) and
shape, but with smal focal cortical thickness. Below: intraoperative identification of SLN. After complete axillary dis‐
section, the sentinel lymph and all the other nodes were negative.
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Preoperative ultrasound associated with ultrasound-guided biopsy can be used for preoper‐
ative axillary staging in patients who will be referred to preoperative systemic therapy. Study
of Joh et al, in reference [14], showed that planning and initiation of preoperative systemic
therapy can reliably be done using ultrasound axillary evaluation and biopsy.
The future protocols of breast cancer treatment will probably include ultrasound as a step in 
preoperative sentinel node mapping. Ultrasound may reveal abnormalities of axillary 
lymph nodes and guide biopsy of these nodes.  
atients with either normal or abnormal ultraso nd exams, but negative cytology, 
underwent sentinel node mapping. Patients with abnormal ultrasound and positive 
cytology proceeded to complete axillary dissection, in reference [13]. 
There are studies trying to assess the tumoral burden in patient with positive nodes. The 
study of Moore A et al, in [13], indicates that abnormalities limited to the lymph node cortex 
(Figure 9) were indicative of N1 disease.  
 
 
 
Figure 9. Postoperative assessment of ultrasound. The first lymph node during scanning 
towards axilla: metastatic sentinel lymph node with normal size and shape, but with smal 
focal cortical thickness. After complete axillary dissection, the sentinel lymph node was the 
only metastatic lymph node. 
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Figure 10. Left and right: same case – advanced ductal carcinoma (T3 N2 M0). Three lymph 
nodes displaying the features of metastatic disease. Axillary metastases were confirmed by 
core biopsy, and the patient was referred to preoperative chemotherapy. 
 
Preoperative ultrasound associated with ultrasound-guided biopsy can be used for 
preoperative axillary staging in patients who will be referred to preoperative systemic 
therapy. Study of Joh et al, in reference [14], showed that planning and initiation of 
preoperative systemic therapy can reliably be done using ultrasound axillary evaluation and 
biopsy. 
 
4.6 Percutaneous biopsy procedures 
 
Unfortunetly, no imaging technique has enough reliability to attribute patients directly to 
complete axillary dissection, without first performing SLNB. The study of Valente SA, Sener 
SF et al, in [15], evaluated retrospectively 244 consecutive patients diagnosed with invasive 
breast carcinoma, by physical examination of the axilla, digital mammography, axillary 
4.6.1 Percutaneous biopsy procedures in operable breast cancer 
Figure 10. Left and right: same case – adv nced ductal carcinoma (T3 N2 M0). Three lymph nodes displaying the fea‐
tures of metastatic disease. Axillary metastases were confirmed by core biopsy, and the patient was referred to preop‐
erative chemotherapy.
4.6. Percutaneous bi psy procedur s
Unfortunetly, no imaging technique has enough reliability to attribute patients d rectly to
com l te axillary dissection, without first performing SLNB. The study of Valente SA, Sener
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SF et al, in [15], evaluated retrospectively 244 consecutive patients diagnosed with invasive
breast carcinoma, by physical examination of the axilla, digital mammography, axillary
ultrasonography, and contrast enhanced breast magnetic resonance imaging. The authors
found that from the patients who had all four modalities negative, 14% were ultimately found
to have histologically positive nodes at the time of surgery.
The role of ultrasound in staging breast cancer differs with stage of disease, helping treatment
decisions for surgery, chemotherapy, and radiation therapy.
4.6.1. Percutaneous biopsy procedures in operable breast cancer
In operable breast cancer, ultrasound helps identification of sentinel lymph node and of
suspicious nodes, that warrant biopsy. Ultrasound alone has modest accuracy in detecting
axillary metastasis, not being reliable, on its own, to make a decision in surgical treatment of
the axilla. Ultrasound does not provide enough information to refer patients to complete
axillary dissection.
The reported a median ultrasound sensitivity, in a meta-analysis of 21 studies, including 4313
patients, made by Houssami et al, was 61.4% [51.2%-79.4%], and the median ultrasound
specificity was 82.0% (76.9%-89.0%), in reference [16]. Adding a axillary biopsy procedure to
ultrasound, to assess patients with abnormal or suspicious axillary nodes, leads to a good
sensitivity and excellent specificity (nearly 100%). The same meta-analysis, made by Houssami
et al, in [16], evaluated 1733 patients, in whom needle biopsy was added and guided by
ultrasound, because of abnormal findings. In these patients, the ultrasound-guided biopsy had
median sensitivity of 79.4% (68.3%-8.9%) and a median specificity of 100% (100%-100%).
The study of Holwit DM, Margenthaler JA, in [17], retrospectively performed on 256 patients
with clinically node-negative breast cancer, who underwent axillary ultrasound (AUS)
evaluation and ultrasound-guided FNAB/needle core biopsy only in suspicious-appearing
lymph nodes, found that the sensitivity and specificity of axillary ultrasound alone were 79%
and 81%, respectively. The overall combined sensitivity and specificity for AUS-guided FNAB/
needle core biopsy were 71% and 99%, respectively, with a negative predictive value of 84%
and a positive predictive value of 97%.
Axillary UNB has a good clinical utility, based on a meta-analysis of Houssami N, Diepstraten
SCE et al, in [18], on 7097 patients, with a percent of 18.4% of patients effectively referred to
axillary treatment thus avoiding SNB.
4.6.2. Percutaneous biopsy procedures in locally advanced breast cancer
Locally advanced stages of the disease are usually associated with obvious ultrasound features
of axillary node involvement, and ultrasound helps the biopsy of these nodes, in most cases
reffering the patient to systemic preoperative treatment.
Ultrasound examination and US-guided biopsy may the only possibility to diagnose the breast
cancer that presents with no identifiable breast tumor and clinically positive axillary metastasis
only. When mammography is negative, biopsy of the clinically positive lymph node is the only
Mammography Techniques and Review32
way to obtain a specimen for pathology and ultrasound could help localization and guiding
the procedure.
The advantages of preoperative systemic therapy include the potential downsizing of large
tumors for either conversion of inoperable disease to resectable lesions or conversion of
patients to breast conservation therapy, and in vivo assessment of the response of the tumor
to chemotherapy, in reference [19]. Algorithms were issued for attributing patients to preop‐
erative systemic therapy.
 
 
Figure 11. Patient presenting with palpable axillary lymph node. No breast tumor could be 
identified (mammography negative). Multiple passes were performed on the breast for core-
biopsy, and the palpable node was removed by open surgery. Pathology showed axillary 
metastasis of invasive ductal carcinoma, with areas of mucinous carcinoma and failed to 
confirm the presence of the disease at the breast level. 
 
The advantages of preoperative systemic therapy include the potential downsizing of large 
tumors for either conversion of inoperable disease to resectable lesions or conversion of 
patients to breast conservation therapy, and in vivo assessment of the response of the tumor 
to chemotherapy, in reference [19]. Algorithms were issued for attributing patients to 
preoperative systemic therapy. 
 
Figure 11. Patient presenting with palpable axillary lymph node. No breast tumor could be identified (mammography
negative). Multiple passes were performed on the breast for core-biopsy, and the palpable node was removed by open
surgery. Pathology showed axillary metastasis of invasive ductal carcinoma, with areas of mucinous carcinoma and
failed to confirm the presence of the disease at the breast level.
Lee at al, in [20], consider onographically d tect d axilla y metastas  as a clinically positive
axilla, so complete ALND is recommended for patients with positive axillary biopsy, even with
a clinically negative axilla, after neoadjuvant c emotherapy.
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Figure 12. Algorithm for axillary assessment in patients with locally advanced invasive 
breast cancer (adapted from Lee MC et al, in [20]). 
 
Lee at al, in [20], consider sonographically detected axillary metastases as a clinically 
positive axilla, so complete ALND is recommended for patients with positive axillary 
biopsy, even with a clinically negative axilla, after neoadjuvant chemotherapy. 
 
5. Conclusion  
 
Axillary staging for breast cancer evolved from axillary lymph node dissection towards the 
lesser invasive sentinel lymph node biopsy.  Nowadays, although SLNB remains the 
standard procedure for diagnosing axillar involvement, axillary ultrasonography is 
performed as the initial staging examination breast cancer patients. 
Invasive breast cancer
T2 or above 
Axillary ultrasound 
imaging 
Normal  Abnormal or 
suspicious 
SLNB FNAB or core biopsy 
Negative  Positive  Positive  Negative  
Complete axillary 
dissection 
usually post 
chemotherapy 
No axillary dissectionComplete axillary 
dissection 
pre- or post 
chemotherapy 
Figure 12. Algorithm for axillary assessment in patients with locally advanced invasive breast cancer (adapted from
Lee MC et al, in [20]).
5. Conclusion
Axillary staging for breast cancer evolved from axillary lymph node dissection towards the
lesser invasive sentinel lymph node biopsy. Nowadays, although SLNB remains the standard
procedure for diagnosing axillar involvement, axillary ultrasonography is performed as the
initial staging examination breast cancer patients.
In operable breast cancer, ultrasound helps identification and guide biopsy of sentinel lymph
node, and/or other imaging suspicious-appearing lymph nodes. As axillary ultrasonography
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with either FNAB or core-biopsy is a far less invasive approach to diagnose lymph node
metastasis, approximately 15 % of breast cancer patients will avoid an unnecessary SLNB and
proceed directly to complete axillary dissection.
For patients with locally advanced invasive breast cancer, the recent years brought a growing
practice of the routine axillary ultrasound imaging, with early referral of patients to preoper‐
ative systemic chemotherapy.
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